NCT07739784Recruiting
This Study Examines Whether Personality Traits Influence the Frequency or Severity of Ocular Adverse Effects Reported by Patients Using Glaucoma Medications. The Findings May Identify Patients at Greater Risk of Intolerance and Support More Personalized Treatment and Counselling.
Personality Traits and Their Relation to Ocular Adverse Effects From Glaucoma Medications
Source: ClinicalTrials.gov · Last updated 31 Jul 2026
Brief summary (registry, in English)
The goal of this observational study is to learn whether personality traits are related to eye side effects from glaucoma medications in adults who currently use or previously used these medications. The main questions this study aims to answer are: Are certain personality traits associated with the occurrence or severity of eye side effects from glaucoma medications? Do personality traits differ between people who experience these side effects and those who do not? Participants will complete a questionnaire that measures five personality traits: openness, conscientiousness, extraversion, agreeableness, and neuroticism. They will also provide basic demographic information. The researchers will review participants' medical records to collect information about their glaucoma medications and any related eye side effects, including the type and frequency of side effects and whether treatment was changed because of them. Participation involves one session lasting approximately 30 minutes. Questionnaires may be completed securely online or in person at the clinic. The study will include approximately 352 adults. No treatment will be assigned or changed as part of this study.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 352 (estimated)
- First submitted
- 28 Jul 2026
- Start date
- 25 Feb 2026
- Primary completion date
- 1 Jul 2027
- Lead sponsor
- McGill University Health Centre/Research Institute of the McGill University Health Centre
- Diseases
- Glaucoma
- NCT number
- NCT07739784
What you commit to
- Study type: Observational
- Planned participants: 352
- From 25 Feb 2026 to the primary completion date, 1 Jul 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Uncontrolled anxiety or depression that was present before glaucoma medication treatment began.
Other
- Unable to provide informed consent.
- Unable to complete the study questionnaires in English or French.
Who the study is looking for
- Age 18 years or older.
- Diagnosis of glaucoma.
- Current or previous treatment with one or more glaucoma medications.
- Able to provide informed consent.
- Able to complete the study questionnaires in English or French.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| McGill University Health Center Coordinator of this site? Confirm its status | Montreal | Canada | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.